Form 8-K · Current report
Northrop Grumman 8-K, filed Aug 21, 2026
- Filed
- CIK
- 0001133421
- Accession no.
- 0001628280-26-058480
Summary
Northrop Grumman's independent board members approved a one-time performance-based equity grant to Chair, CEO and President Kathy J. Warden, covering up to 150% of a target 35,910 market stock units based on the company's absolute stock price appreciation or depreciation through December 31, 2031.
Key points
- The grant pays 0% if the stock depreciates by more than 25% and 150% if it appreciates by 50% or more; target payout requires at least 10% appreciation.
- The award is generally contingent on Warden's continued service through the performance period ending December 31, 2031.
- The independent directors said the award recognizes and is intended to sustain her leadership contributions and align her interests with shareholders and customers.
- The grant is governed by the applicable Market Stock Units Grant Agreement.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
From the filing
ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (e) On August 19, 2026, the independent members of the Board of Directors of Northrop Grumman Corporation (the “Company”) approved a one-time grant of performance-based equity to Kathy J. Warden, Chair, Chief Executive Officer and President. This award recognizes and is intended to sustain Ms. Warden’s critical leadership contributions and strengthens alignment of her interests with those of the Company’s shareholders and customers. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.